Narrative Review: Aspirin Resistance and Its Clinical Implications
- 1 March 2005
- journal article
- review article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 142 (5), 370-380
- https://doi.org/10.7326/0003-4819-142-5-200503010-00012
Abstract
Aspirin is currently the most cost-effective drug for the secondary prevention of cardiovascular disease, but treatment failures are relatively common. Several factors have been linked to these recurrent vascular events in patients prescribed aspirin, including smoking, drug interactions, nonadherence, comorbid conditions, and aspirin resistance. The term aspirin resistance has been used to describe not only an absence of the expected pharmacologic effects of aspirin on platelets but also poor clinical outcomes, such as recurrent vascular events, in patients treated with aspirin. Aspirin resistance is perhaps more precisely understood as the phenomenon of measurable, persisting platelet activation that occurs in patients prescribed a therapeutic dose of aspirin and may underlie an unknown proportion of aspirin treatment failures. Key challenges for future research are to standardize a definition of aspirin resistance and to compare whether different measures of platelet activation, either alone or in combination, independently predict cardiovascular events. These challenges must be met before researchers conduct studies to assess the clinical utility of testing on patient outcomes and cost-effective prescribing.Keywords
This publication has 47 references indexed in Scilit:
- Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side EffectsChest, 2004
- The antithrombotic profile of aspirin. Aspirin resistance, or simply failure?Thrombosis Journal, 2004
- Indirect comparison meta-analysis of aspirin therapy after coronary surgeryBMJ, 2003
- Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary interventionJournal of the American College of Cardiology, 2003
- How should meta‐regression analyses be undertaken and interpreted?Statistics in Medicine, 2002
- The laboratory diagnosis of platelet disorders.Published by Wiley ,2002
- Cyclooxygenase Inhibitors and the Antiplatelet Effects of AspirinNew England Journal of Medicine, 2001
- Aspirin resistance after coronary artery bypass graftingThe Journal of Thoracic and Cardiovascular Surgery, 2001
- Aspirin Improves Endothelial Dysfunction in AtherosclerosisCirculation, 1998
- Aspirin protects low density lipoprotein from oxidative modification.Heart, 1997